Pharmacy middleman fuels lobbying electric shock

December 10, 2021

Although there is little agreement between PBM opponents on what Congress should do, industry lobbyists offer a menu of options for Democrats to consider. They can also claim more health insurance than PBM pays to the pharmacy that dispenses the drug and ban a common practice called spread pricing that puts the difference in your pocket. PBM claims to be scapegoated, responding with its own lobbying and advertising blitz.

Read the source article at United Kingdom Eminetra Today
2021-12-04 12:09:18

Share This Story!